login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
TELESIS BIO INC (TBIO) Stock News
USA
- NASDAQ:TBIO -
US1920032000
-
Common Stock
3.23
USD
-0.76 (-19.05%)
Last: 9/27/2024, 8:22:41 PM
2.85
USD
-0.38 (-11.76%)
After Hours:
9/27/2024, 8:22:41 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
TBIO Latest News, Press Relases and Analysis
All
Press Releases
6 months ago - By: Yahoo Finance
- Mentions:
REGN
SCYX
PEPG
NVDA
...
Regeneron Pharmaceuticals, Inc. (REGN) Licenses Gibson SOLA Platform to Boost R&D Efficiency
6 months ago - By: Telesis Bio
- Mentions:
OTC
Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene Synthesis
8 months ago - By: Telesis Bio
- Mentions:
OTC
Telesis Bio Secures up to $21 Million to Accelerate Adoption of Groundbreaking Gibson SOLA Technology for Rapid DNA and mRNA Synthesis
a year ago - By: Benzinga
What's Going On With Telesis Bio Shares Thursday?
a year ago - By: Benzinga
- Mentions:
MU
MDXH
DUO
KTTA
...
Nasdaq Gains Over 1%; Micron Posts Upbeat Q4 Results
a year ago - By: BusinessInsider
TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q2 2024
2 years ago - By: BusinessInsider
TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q1 2024
2 years ago - By: Telesis Bio
Telesis Bio Reports First Quarter 2024 Financial Results
a year ago - By: Telesis Bio
Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
a year ago - By: Telesis Bio
Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
2 years ago - By: Telesis Bio
Telesis Bio Announces Reverse Stock Split
a year ago - By: Telesis Bio
Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
a year ago - By: Telesis Bio
Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
a year ago - By: InvestorPlace
TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q2 2024
a year ago - By: Telesis Bio
Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
a year ago - By: Telesis Bio
Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
a year ago - By: InvestorPlace
- Mentions:
BSFC
VLCN
UBS
CNSP
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
2 years ago - By: InvestorPlace
TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q1 2024
2 years ago - By: Telesis Bio
Telesis Bio Reports First Quarter 2024 Financial Results
2 years ago - By: Telesis Bio
Telesis Bio Announces Reverse Stock Split
Please enable JavaScript to continue using this application.